Medical Oncology

, Volume 27, Issue 1, pp 105–107 | Cite as

High prevalence of restless legs syndrome among patients with polycytemia vera treated with venesectio

  • Magnus Tobiasson
  • Bassam Alyass
  • Susanne Söderlund
  • Gunnar Birgegård
Original Paper


In order to examine whether symptoms of iron deficiency anemia are due to the iron deficiency itself or the associated anemia, 34 patients with polycytemia vera (PV) treated with venesectio, who had iron deficiency but normal hemoglobin (Hb) levels, were given a questionnaire covering symptoms of iron deficiency including the international RLS-scale and the Fact-fatigue quality of life scale (QoL). We found a prevalence of pica of 11.7%, mouth paresthesias of 5.8% and rest-less legs 29.6% (RLS “normal” prevalence 10%). Thus, the prevalence of RLS is significantly higher in our population. We also saw a significant difference in QoL between patients with and without RLS (P = 0.015) and QoL correlated with the severity of RLS (R = 0.85). In conclusion, RLS seems to be a frequent and serious problem for PV patients treated with venesectio according to standard guidelines.


Polycytemia vera Iron deficiency Restless legs syndrome Venesectio treatment 


  1. 1.
    McMullin MF, Reilly JT, Campbell P, et al. Amendment to the guideline for diagnosis and investigation of polycythaemia/erythrocytosis. Br J Haematol. 2007;138:821–2. doi: 10.1111/j.1365-2141.2007.06741.x.CrossRefPubMedGoogle Scholar
  2. 2.
    Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med. 2004;5:385–91. doi: 10.1016/j.sleep.2004.01.012.CrossRefPubMedGoogle Scholar
  3. 3.
    Eftekhari MH, Keshavarz SA, Jalali M, Elguero E, Eshraghian MR, Simondon KB. The relationship between iron status and thyroid hormone concentration in iron-deficient adolescent Iranian girls. Asia Pac J Clin Nutr. 2006;15:50–5.PubMedGoogle Scholar
  4. 4.
    Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13:63–74. doi: 10.1016/S0885-3924(96)00274-6.CrossRefPubMedGoogle Scholar
  5. 5.
    Walters AS, Le Brocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4:121–32. doi: 10.1016/S1389-9457(02)00258-7.CrossRefPubMedGoogle Scholar
  6. 6.
    Ulfberg J, Nystrom B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord. 2001;16:1159–63. doi: 10.1002/mds.1209.CrossRefPubMedGoogle Scholar
  7. 7.
    Winkelman JW, Finn L, Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med. 2006;7:545–52. doi: 10.1016/j.sleep.2006.01.004.CrossRefPubMedGoogle Scholar
  8. 8.
    Tison F, Crochard A, Leger D, Bouee S, Lainey E, El Hasnaoui A. Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study. Neurology. 2005;65:239–46. doi: 10.1212/01.wnl.0000168910.48309.4a.CrossRefPubMedGoogle Scholar
  9. 9.
    Bjorvatn B, Leissner L, Ulfberg J, et al. Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries. Sleep Med. 2005;6:307–12. doi: 10.1016/j.sleep.2005.03.008.CrossRefPubMedGoogle Scholar
  10. 10.
    Ulfberg J, Nystrom B, Carter N, Edling C. Restless Legs Syndrome among working-aged women. Eur Neurol. 2001;46:17–9. doi: 10.1159/000050750.CrossRefPubMedGoogle Scholar
  11. 11.
    Kiladjian JJ, Cassinat B, Chevret S, et al. Pegylated Interferon-alfa-2a induces complete hematological and molecular responses with low toxicity in Polycythemia Vera. Blood. 2008;112:3065–72.CrossRefPubMedGoogle Scholar
  12. 12.
    Ricksten A, Palmqvist L, Johansson P, Andreasson B. Rapid decline of JAK2V617F levels during hydroxyurea treatment in patients with polycythemia vera and essential thrombocythemia. Haematologica. 2008;93(8):1260–1. doi: 10.3324/haematol.12801.CrossRefPubMedGoogle Scholar

Copyright information

© Humana Press Inc. 2009

Authors and Affiliations

  • Magnus Tobiasson
    • 1
  • Bassam Alyass
    • 1
  • Susanne Söderlund
    • 2
  • Gunnar Birgegård
    • 3
  1. 1.MälarsjukhusetEskilstunaSweden
  2. 2.CentrallasarettetVasterasSweden
  3. 3.Department of HaematologyUniversity HospitalUppsalaSweden

Personalised recommendations